Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

SHE Day: The Strong, HIV Positive, Empowered Women (SHE) Faculty and Bristol-Myers Squibb Celebrated Four Years of SHE, a First-of-Its Kind Programme Addressing the Specific Challenges Faced by Women Living with HIV in Europe


News provided by

Bristol Myers Squibb

30 Jun, 2014, 08:00 GMT

Share this article

Share toX

Share this article

Share toX

PARIS, June 30, 2014 /PRNewswire/ --

  • The SHE network continues to expand across Europe to empower and educate women living with HIV and their health care providers 
  • More than 60 SHE units, multidisciplinary teams based in HIV clinics and dedicated to women with HIV, have been implemented in 18 countries

'SHE' (Strong, HIV positive, Empowered Women) experts and Bristol-Myers Squibb hosted on Friday, 27 June a 'SHE Day' in Paris, a yearly meeting that brings together a diverse group of experts including women living with HIV and physicians to discuss how the situation for women can be improved in Europe. SHE is the first integrated peer support and medical education programme aimed at addressing the unmet needs of women living with HIV and the health care providers involved in their care, in Europe.

To view the Multimedia News Release, please click:

http://www.multivu.com/mnr/71400567-she-day-four-year-anniversary-celebration 

Research shows that women represent one third of new diagnoses of HIV in Europe.[i] Even though prognoses have improved, HIV remains complex, providing unique challenges for women living with HIV and their health care providers.[i] SHE aims to address those challenges by offering educational and scientific tools for use in the clinical and community settings.

"Four years ago, women living with HIV and physicians came together to discuss how we can improve the lives of women living with HIV across Europe," said Annette Piecha, SHE community co-chair and member of Kompetenznetz HIV/AIDS e.V., Germany. "The result was the SHE programme. No woman should ever feel alone or isolated - resources such as SHE are needed to empower and unite all of us. During SHE Day, we exchanged our experiences and discussed what else should be done for women living with HIV."

SHE: A Growing Network  

Since its launch, the SHE programme has been rolled out in 18 European countries* with involvement of more than 200 HIV physicians and key patient community groups. Over the past year, the SHE faculty and Bristol-Myers Squibb organised more than 50 peer support workshops to empower and inform women. Additionally, there have been 20 medical education meetings, where physicians were able to present best practices for the clinical care of women.

SHE seeks to promote the best scientific practices and provide women with an optimal and easily accessible health care infrastructure. To date, more than 60 SHE units have been established in HIV clinics and the community settings.

"Each country has an opportunity to adapt the programme content and format based on their local needs," said Celia Miralles, SHE community co-chair, Internal Medicine Department, Hospital Xeral, Vigo, Spain. "For example, in Poland, an anonymous SHE helpline was launched. At the Brussels SHE unit, there is a monthly SHE corner, where women waiting for their follow up appointments are provided with support and information. In Spain, I had the opportunity to implement a SHE unit in my hospital and also collaborate with SEISIDA to issue an evaluation report on the programme."

SHE Resources Tailored to Women's Needs 

The SHE units are supported by a vast array of resources, including peer support and medical toolkits.

"The scientific work was an important part of SHE day, and the faculty remains dedicated to exploring the current landscape for women, identifying areas where additional knowledge is needed and preparing educational materials for HIV health care providers," said Professor Margaret Johnson, SHE scientific co-chair, HIV Clinic, Royal Free Hospital, London, U.K.

*Austria, Belgium, Denmark, Germany, Greece, Finland, France, Ireland, Italy, Norway, Poland, Portugal, Romania, Russia, Spain, Sweden, Switzerland, United Kingdom  

The faculty also discussed community materials, with a special focus on the peer support toolkit, which is available and adapted for local country use. The new UK section dedicated to women and migration was presented at the meeting. The UK faculty found that there are higher rates of HIV infection among migrants, compared to national populations[ii] with women being at greater risk than men due to biological, social and cultural factors.[ii],[iii]

About the SHE Programme 

SHE (Strong, HIV positive, Empowered women) aims to improve the care and quality of life of women living with HIV through empowerment and education. In addition to supplying new scientific and educational tools to women living with HIV, SHE encourages building a dialogue with physicians and sharing experiences with other women living with HIV. Steered independently by a faculty involving women personally living with HIV, health care providers, advocacy group members, and policymakers from ten European countries, SHE is funded and organised by Bristol-Myers Squibb.

For more information about the SHE programme, visit http://www.SHEtoSHE.org.

Bristol-Myers Squibb's Commitment to Virology

For over 20 years, Bristol-Myers Squibb has worked collaboratively with the virology community to help meet the needs of patients living with HIV, HBV and HCV.

Bristol-Myers Squibb supports a number of scientific and educational programmes within the virology community around the world that encompass disease education, disease awareness and sharing of best practices. In addition to SHE, these include PATH B® (Patients and professionals acting together for hepatitis B), a joint initiative between hepatitis patient groups and hepatologists to provide comprehensive information and support for patients with chronic hepatitis B and Partnering for Cure, a pan-European scientific initiative supporting breakthrough research and facilitating greater collaboration and knowledge-sharing with the virology community.

Additionally, Bristol-Myers Squibb Foundation's philanthropic and educational programmes, such as Secure the Future® and Delivering Hope® aim to support people living with HIV in Africa and with viral hepatitis in Asia, through numerous private-public partnerships and community based projects.

[1]

i. Association for Women's Rights in Development (AWID): "Women Living With HIV Are Part Of Response To HIV/AIDS - Challenging The Action Plan On HIV/AIDS In The EU And Neighbouring Countries: 2014-2016," 30 April 2014. Available at http://www.awid.org/News-Analysis/Announcements2/Women-living-with-HIV-are-part-of-response-to-HIV-AIDS-challenging-the-Action-Plan-on-HIV-AIDS-in-the-EU-and-neighbouring-countries-2014-2016. Accessed June 2014.

ii. International Organization for Migration (IOM). Maternal and Child Healthcare for Immigrant  Populations, 2009. Available at http://www.migrant-health-europe.org/files/Maternal%20and%20Child%20Care_Background%20Paper(1).pdf. Accessed June 2014.

iii. World Health Organization (WHO). Gender inequalities and HIV, 2014. Available from: http://www.who.int/gender/hiv_aids/en/index.html. Accessed June 2014.

Media: Joanna Ritter, +33(0)1 5883 6509, joanna.ritter@bms.com


Video: 
     http://www.multivu.com/mnr/71400567-she-day-four-year-anniversary-celebration

Modal title

Also from this source

Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia & Gulf Countries

Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia & Gulf Countries

Bristol Myers Squibb, a leading global biopharmaceutical company, has recently appointed Osama Braiwish as its General Manager for Saudi Arabia and...

Bristol Myers Squibb Marks 10 Years of Global Patient Week with Community Initiatives in the Region

Bristol Myers Squibb Marks 10 Years of Global Patient Week with Community Initiatives in the Region

To mark the 10th anniversary of its Global Patient Week, Bristol Myers Squibb, a leading global biopharmaceutical company, organized patient-focused...

More Releases From This Source

Explore

Education

Education

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Trade Show News

Trade Show News

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.